Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Students in the Pottsville Junior High School EAST Program are using their skills to help caregivers with loved ones who have dementia or Alzheimer's.

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...

In the United States, most people with dementia don't know they have it. A new study has found that four out of five people ...

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...

The FDA last month accepted the application for subcutaneous Leqembi for maintenance dosing, with a target action date of ...

Q4 2024 Earnings Call Transcript February 6, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease.

The last Friday of January has traditionally been reserved for Blizzard Blast, the Allina Hospice Foundation fundraiser. It’s an annual event that brings in thousands of dollars in donations that are ...

A ruling may come this month on UnitedHealth's motion to dismiss a lawsuit stemming from STAT reporting on the firm's use of ...